SMLR
Semler Scientific, Inc.
Set alert
- YTD
- +32.96%
- 1 year
- -68.69%
- Open
- 20.33
- Prev close
- 20.33
- Mkt cap
- 571.43M
- Vol
- 1.62M
- Avg vol
- 610.88K
- EPS
- 2.04
- P/E
- 30.23
- Div yield
- 0.00%
More statistics
- Low
- 20.33
- High
- 20.33
- Forward P/E
- 18.30
- Beta
- 0.92
- Short ratio
- 1.35
- Inst. own
- 43.48%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 47.31
- 200-d avg
- 33.35
- 1y target
- 40.00
Key statistics
- Market cap
- 571.43M
- Enterprise value
- 436.33M
- Trailing P/E
- 30.23
- Forward P/E
- 18.30
- PEG ratio
- 0.00
- Price / sales
- 9.70
- Price / book
- 5.14
- EPS (TTM)
- 2.04
- Beta
- 0.92
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 27.00%
- Revenue (TTM)
- 58.94M
- Revenue growth
- -17.20%
- Free cash flow
- -56.74M
- Total cash
- 12.67M
- Total debt
- 93.00K
- Return on equity
- 20.39%
- Shares outstanding
- 9.27M
- Short % of float
- 18.97%
- 50-day average
- 47.31
- 200-day average
- 33.35
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.20.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2024 | Sep 1, 2024 | 0.00 | 0.72 | — | — |
| Aug 5, 2024 | Jun 1, 2024 | 0.00 | 0.00 | — | — |
| May 7, 2024 | Mar 1, 2024 | 0.00 | 0.78 | — | — |
| Mar 5, 2024 | Dec 1, 2023 | 0.00 | 0.55 | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | 0.71 | — | — |
| Aug 10, 2023 | Jun 1, 2023 | 0.00 | 0.75 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2022 | B. Riley Securities | down | Buy | Neutral |
| May 3, 2022 | B. Riley Securities | main | — | Buy |
| Mar 7, 2022 | B. Riley Securities | main | — | Buy |
| Nov 2, 2021 | B. Riley Securities | main | — | Buy |
| Oct 26, 2021 | B. Riley Securities | main | — | Buy |
| May 4, 2021 | B. Riley Securities | main | — | Buy |
About Semler Scientific, Inc.
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- semlerscientific.com
News
- Kuehn Law Encourages Investors of Semler Scientific to Contact Law Firm
- Analysts Set Semler Scientific Inc. (NASDAQ:SMLR) Price Target at $74.25
- Generali Asset Management SPA SGR Grows Stock Holdings in Semler Scientific Inc. $SMLR
- Analysts Set Semler Scientific Inc. (NASDAQ:SMLR) PT at $74.25
- Semler Scientific (NASDAQ:SMLR) & Vasamed (OTCMKTS:VSMD) Head-To-Head Survey
- Semler Scientific Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Semler Scientific, Inc. - SMLR
- Crypto's Hottest Trade Crumples
- SMLR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Merger of Semler Scientific With Strive Asset Management
- Earnings Scheduled For November 12, 2025
- Semler Scientific® to Release Third Quarter 2025 Financial Results
Your note
Sign in to keep a note on SMLR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| LEIBOWITZ ARTHUR N | Director | Stock Award(Grant) | Jan 31, 2023 | 4,865 |
| MESSINA DANIEL S | Director | Stock Award(Grant) | Nov 6, 2024 | 11,910 |
| MOON CINDY | Director | Stock Award(Grant) | Jan 31, 2023 | 3,211 |
| MURPHY-CHUTORIAN DOUGLAS | Chief Executive Officer | Stock Gift | Dec 11, 2024 | 155,313 |
| PAN WAYNE T | Director | Stock Award(Grant) | Jan 31, 2023 | 47,554 |
| SEMLER ERIC | Director | Conversion of Exercise of derivative security | Dec 15, 2024 | 707,367 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Cerity Partners LLC | 19.92% | 1,345,586 | 82.97M | Sep 29, 2024 |
| Blackrock Inc. | 5.43% | 366,564 | 22.60M | Sep 29, 2024 |
| Vanguard Group Inc | 4.61% | 311,624 | 19.21M | Sep 29, 2024 |
| Dimensional Fund Advisors LP | 2.74% | 185,282 | 11.42M | Sep 29, 2024 |
| ShariaPortfolio, Inc. | 2.27% | 153,616 | 9.47M | Sep 29, 2024 |
| Geode Capital Management, LLC | 2.01% | 135,959 | 8.38M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.69% | 181,351 | 11.18M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.78% | 119,988 | 7.40M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.17% | 79,034 | 4.87M | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.73% | 49,299 | 3.04M | Aug 30, 2024 |
| iShares Russell 2000 Growth ETF | 0.66% | 44,679 | 2.75M | Oct 30, 2024 |
| Fidelity Extended Market Index Fund | 0.47% | 31,940 | 1.97M | Oct 30, 2024 |